GLP-1 (Glucagon-like Peptide-1) Receptor Agonist: Focuses on insulin secretion, glucose-dependent insulin sensitivity, and suppressing appetite via the brain's reward centers
Again, some level of consideration will have to be made for initial starting BMI, but just like the obese patients, a treat-to-target dose that considers weight + A1c goals should be the aim going forward
The Timeline of Side Effects During dose escalation (weeks 1-12), gastrointestinal symptoms dominate
The product is no longer viable
Supplies needed for reconstitution (bacteriostatic water, insulin syringes, alcohol swabs) add a minor monthly cost for either compound
Erectile dysfunction has many causes, and a doctor can help you find the best treatment